XBiotech Inc. SEC filings XBIT

XBiotech Inc. has 407 filings in SEC EDGAR's recent list, going back to Dec 10, 2014. Its latest annual report, Form ARS, was filed on Oct 2, 2026 for the period ended Oct 2, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (officer or director change). The company's fiscal year ends on December 31.

XBiotech Inc. SEC filings
Form Description Filed Period
4 Insider transaction Oct 28, 2026 Oct 26, 2026
3 Initial insider ownership Oct 28, 2026 Oct 23, 2026
4 Insider transaction Oct 28, 2026 Oct 26, 2026
8-K Current report
Officer or director change
Oct 26, 2026 Oct 23, 2026
ARS Annual report to shareholders Oct 2, 2026 Oct 2, 2026
DEF 14A Proxy statement Oct 2, 2026 Nov 24, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
10-K/A Amended annual report Apr 29, 2026 Dec 31, 2025
10-K Annual report Mar 13, 2026 Dec 31, 2025
S-8 Employee stock plan registration Mar 11, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 23, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 23, 2026 —
8-K Current report
Officer or director change
Dec 9, 2025 Dec 5, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
4 Insider transaction Nov 12, 2025 Oct 1, 2025
4 Insider transaction Nov 12, 2025 Oct 1, 2025
4 Insider transaction Nov 12, 2025 Oct 1, 2025
4 Insider transaction Nov 12, 2025 Oct 1, 2025
8-K/A Amended current report
Officer or director change
Oct 15, 2025 Jun 24, 2025
8-K Current report
Material agreement, Officer or director change
Oct 3, 2025 Oct 1, 2025
3 Initial insider ownership Sep 30, 2025 Aug 29, 2025
3 Initial insider ownership Sep 30, 2025 Aug 29, 2025
3 Initial insider ownership Sep 29, 2025 Aug 29, 2025
3 Initial insider ownership Sep 16, 2025 Aug 29, 2025
8-K Current report
Shareholder vote results
Sep 2, 2025 Aug 29, 2025
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
ARS Annual report to shareholders Jul 7, 2025 Dec 31, 2024
DEF 14A Proxy statement Jul 7, 2025 Aug 29, 2025
8-K Current report
Officer or director change
Jun 24, 2025 Jun 24, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
10-K/A Amended annual report Apr 29, 2025 Dec 31, 2024
8-K Current report
Listing notice
Apr 7, 2025 Apr 1, 2025
8-K Current report
Officer or director change
Apr 1, 2025 Mar 27, 2025
4 Insider transaction Mar 19, 2025 Mar 17, 2025
10-K Annual report Mar 18, 2025 Dec 31, 2024
4 Insider transaction Feb 4, 2025 Jan 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 27, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 27, 2025 —
8-K Current report
Officer or director change
Dec 31, 2024 Dec 31, 2024
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
10-Q Quarterly report Aug 12, 2024 Jun 30, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
8-K Current report
Shareholder vote results
Jun 20, 2024 Jun 20, 2024
10-Q Quarterly report May 10, 2024 Mar 31, 2024
ARS Annual report to shareholders May 1, 2024 Dec 31, 2023
DEFA14A Additional proxy material May 1, 2024 —
DEF 14A Proxy statement May 1, 2024 Jun 20, 2024
10-K/A Amended annual report May 1, 2024 Dec 31, 2023
10-K/A Amended annual report Apr 24, 2024 Dec 31, 2023
10-K Annual report Mar 15, 2024 Dec 31, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 7, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 7, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 7, 2024 —
4 Insider transaction Jan 5, 2024 Jan 3, 2024
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Jan 4, 2024 Jan 3, 2024
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
4 Insider transaction Jun 26, 2023 Jun 23, 2023
4 Insider transaction Jun 26, 2023 Jun 23, 2023
4 Insider transaction Jun 26, 2023 Jun 23, 2023
4 Insider transaction Jun 26, 2023 Jun 23, 2023
8-K Current report
Shareholder vote results
Jun 23, 2023 Jun 23, 2023
SC TO-I/A Filing Jun 20, 2023 —
SC TO-I Filing May 17, 2023 —
10-Q Quarterly report May 10, 2023 Mar 31, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Jun 23, 2023
10-K Annual report Mar 15, 2023 Dec 31, 2022
3 Initial insider ownership Feb 23, 2023 Feb 10, 2023
4 Insider transaction Feb 17, 2023 Feb 10, 2023
8-K Current report
Officer or director change
Feb 15, 2023 Feb 3, 2023
SC 13G Ownership over 5% (passive) Feb 10, 2023 —
SC 13G Ownership over 5% (passive) Feb 10, 2023 —
SC 13G Ownership over 5% (passive) Feb 10, 2023 —
SC 13G Ownership over 5% (passive) Jan 12, 2023 —
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
10-Q Quarterly report Aug 10, 2022 Jun 30, 2022
8-K Current report
Shareholder vote results
Jun 29, 2022 Jun 22, 2022
4 Insider transaction Jun 27, 2022 Jun 22, 2022
4 Insider transaction Jun 27, 2022 Jun 22, 2022
4 Insider transaction Jun 27, 2022 Jun 22, 2022
4 Insider transaction Jun 27, 2022 Jun 22, 2022
SC 13G Ownership over 5% (passive) Jun 16, 2022 —
DEFA14A Additional proxy material May 13, 2022 —
DEF 14A Proxy statement May 13, 2022 Jun 22, 2022
8-K Current report
Auditor change
May 13, 2022 May 11, 2022
10-Q Quarterly report May 10, 2022 Mar 31, 2022
10-K Annual report Mar 15, 2022 Dec 31, 2021
SC 13G Ownership over 5% (passive) Feb 16, 2022 —
SC 13G Ownership over 5% (passive) Feb 16, 2022 —
4 Insider transaction Feb 15, 2022 Oct 15, 2021
8-K Current report
Material agreement
Feb 2, 2022 Feb 2, 2022
4 Insider transaction Jan 13, 2022 Dec 16, 2021
SC 13G Ownership over 5% (passive) Jan 13, 2022 —
4 Insider transaction Nov 23, 2021 Nov 19, 2021
4 Insider transaction Nov 23, 2021 Nov 19, 2021
10-Q Quarterly report Nov 9, 2021 Sep 30, 2021
4 Insider transaction Oct 15, 2021 Oct 7, 2021
4 Insider transaction Oct 6, 2021 Oct 4, 2021
4 Insider transaction Oct 1, 2021 Sep 28, 2021
4 Insider transaction Sep 28, 2021 Sep 23, 2021
4 Insider transaction Sep 22, 2021 Sep 20, 2021
10-Q Quarterly report Aug 9, 2021 Jun 30, 2021
4 Insider transaction Jul 19, 2021 Jul 14, 2021
4 Insider transaction Jul 12, 2021 Jul 9, 2021
4 Insider transaction Jul 12, 2021 Jul 9, 2021
8-K Current report
Other events
Jul 6, 2021 Jul 6, 2021
4 Insider transaction Jun 24, 2021 Jun 22, 2021
4 Insider transaction Jun 24, 2021 Jun 22, 2021
4 Insider transaction Jun 24, 2021 Jun 22, 2021
4 Insider transaction Jun 24, 2021 Jun 22, 2021
10-Q Quarterly report May 10, 2021 Mar 31, 2021
DEFA14A Additional proxy material Apr 29, 2021 —
DEF 14A Proxy statement Apr 29, 2021 Jun 22, 2021
4/A Form 4/a submission Apr 27, 2021 Aug 27, 2020
4 Insider transaction Apr 27, 2021 Aug 27, 2020
4 Insider transaction Mar 22, 2021 Mar 22, 2021
10-K Annual report Mar 16, 2021 Dec 31, 2020
4 Insider transaction Feb 1, 2021 Jan 28, 2021
SC 13G/A Amended ownership over 5% (passive) Dec 23, 2020 —
4 Insider transaction Dec 18, 2020 Dec 18, 2020
4 Insider transaction Dec 2, 2020 Dec 2, 2020
4 Insider transaction Nov 20, 2020 Nov 19, 2020
10-Q Quarterly report Nov 9, 2020 Sep 30, 2020
S-8 Employee stock plan registration Oct 2, 2020 —
4 Insider transaction Sep 21, 2020 Sep 18, 2020
4 Insider transaction Sep 16, 2020 Sep 10, 2020
4 Insider transaction Sep 2, 2020 Sep 1, 2020
4 Insider transaction Sep 1, 2020 Aug 27, 2020
4 Insider transaction Sep 1, 2020 Aug 27, 2020
4 Insider transaction Sep 1, 2020 Aug 27, 2020
4 Insider transaction Sep 1, 2020 Aug 27, 2020
4 Insider transaction Aug 26, 2020 Aug 24, 2020
4 Insider transaction Aug 21, 2020 Aug 17, 2020
10-Q Quarterly report Aug 10, 2020 Jun 30, 2020
8-K Current report
Shareholder vote results
Jun 29, 2020 Jun 26, 2020
10-Q Quarterly report May 11, 2020 Mar 31, 2020
DEFA14A Additional proxy material Apr 29, 2020 —
DEF 14A Proxy statement Apr 29, 2020 Jun 26, 2020
4 Insider transaction Mar 25, 2020 Feb 19, 2020
4/A Form 4/a submission Mar 19, 2020 Feb 12, 2020
4/A Form 4/a submission Mar 19, 2020 Feb 12, 2020
4/A Form 4/a submission Mar 19, 2020 Feb 12, 2020
10-K Annual report Mar 16, 2020 Dec 31, 2019
4/A Form 4/a Mar 5, 2020 Feb 12, 2020
4/A Form 4/a Feb 19, 2020 Feb 12, 2020
SC TO-I/A Filing Feb 19, 2020 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2020 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2020 —
4 Insider transaction Feb 14, 2020 Feb 12, 2020
3 Initial insider ownership Feb 13, 2020 Feb 3, 2020
4 Insider transaction Feb 13, 2020 Feb 3, 2020
4 Insider transaction Feb 13, 2020 Feb 12, 2020
4 Insider transaction Feb 13, 2020 Feb 12, 2020
4 Insider transaction Feb 13, 2020 Feb 12, 2020
SC 13G Ownership over 5% (passive) Feb 13, 2020 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2020 —
SC TO-I/A Filing Feb 13, 2020 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2020 —
SC TO-I/A Filing Feb 13, 2020 —
3 Initial insider ownership Feb 11, 2020 Feb 3, 2020
SC TO-I/A Filing Feb 5, 2020 —
SC 13G/A Amended ownership over 5% (passive) Jan 21, 2020 —
SC TO-I Issuer tender offer statement Jan 14, 2020 —
4 Insider transaction Jan 9, 2020 Jan 6, 2020
8-K Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
Dec 30, 2019 Dec 30, 2019
4 Insider transaction Dec 11, 2019 Dec 6, 2019
8-K Current report
Material agreement, Other events
Dec 9, 2019 Dec 7, 2019
4 Insider transaction Dec 4, 2019 Nov 29, 2019
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
4 Insider transaction Nov 8, 2019 Nov 6, 2019
4 Insider transaction Nov 8, 2019 Nov 6, 2019
4 Insider transaction Sep 9, 2019 Jul 10, 2019
3 Initial insider ownership Sep 9, 2019 Jul 10, 2019
10-Q Quarterly report Aug 9, 2019 Jun 30, 2019
8-K Current report
Officer or director change, Other events
Jul 16, 2019 Jul 10, 2019
4 Insider transaction Jul 1, 2019 Jun 27, 2019
4 Insider transaction Jul 1, 2019 Jun 27, 2019
4 Insider transaction Jul 1, 2019 Jun 27, 2019
4 Insider transaction Jun 28, 2019 Jun 27, 2019
8-K Current report
Shareholder vote results
Jun 20, 2019 Jun 19, 2019
SC 13G/A Amended ownership over 5% (passive) Jun 12, 2019 —
4 Insider transaction Jun 6, 2019 Jun 4, 2019
8-K Current report
Material agreement, Other events
Jun 3, 2019 May 31, 2019
424B5 Prospectus supplement Jun 3, 2019 —
S-3MEF Form s-3 May 31, 2019 —
424B5 Prospectus supplement May 31, 2019 —
8-K Current report
Other events
May 30, 2019 May 30, 2019
8-K Current report
Agreement ended
May 30, 2019 May 30, 2019
10-Q Quarterly report May 9, 2019 Mar 31, 2019
8-K Current report
Material agreement
May 1, 2019 Apr 30, 2019
424B5 Prospectus supplement May 1, 2019 —
DEF 14A Proxy statement Apr 30, 2019 Jun 19, 2019
8-K Current report
Agreement ended
Apr 3, 2019 Mar 29, 2019
10-K/A Amended annual report Mar 15, 2019 Dec 31, 2018

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
XBIT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
British Columbia, Canada
Headquarters
Austin, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1626878

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.